This work is licensed under a Creative Commons Attribution 4.0 International License.
Δ10-19[S2A]GeXIVA
General Information
DRACP ID DRACP06231
Peptide Name Δ10-19[S2A]GeXIVA
Sequence RAPYDRRRRY
Sequence Length 10
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides α9α10nAChR inhibitor
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target α9α10nAChR
Affinity Not available
Mechanism Specifically block the α9α10nAChR
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C60H97N25O15
Absent amino acids CEFGHIKLMNQSTVW
Common amino acids R
Mass 156928
Pl 11.91
Basic residues 5
Acidic residues 1
Hydrophobic residues 1
Net charge 4
Boman Index -8179
Hydrophobicity -284
Aliphatic Index 10
Half Life
Mammalian: 4.4 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 2980
Absorbance 280nm 331.11
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN112010963A
Patent Title Novel alpha O-conotoxin peptide GeXIVA new mutant as well as pharmaceutical composition and application thereof
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.